InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 211274

Monday, 09/26/2016 10:13:34 PM

Monday, September 26, 2016 10:13:34 PM

Post# of 346390
PS Targeting to bring biomarkers from Oct 10 into trials and can even prove a statistically significant reduction of Amyloids? Hmmmm

Wook... FreeTheMice has post#12048 re: Amyloids
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=17496298

I still am amazed at how the shorts were able to cover in time

I now begin to realize that the markets can be manipulated EASILY when needed to be

The Carlyle Group and BlackRock ....will they be able to surpass Ken Dart % in ownership? Hmmmmm I doubt it


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News